SCHEMBL28349896

SCHEMBL28349896

CC1(NC(=O)c2ccccc2)CCCC(Nc2ncc(Cl)c(-c3c[nH]c4ccccc34)n2)C1.CN(C)C/C=C/C(N)=O

nearest known ligand 0.75

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CDK7 P50613 18/20 0.75
▸ CCNH P51946 16/20 0.75
▸ CDK9 P50750 15/20 0.75
▸ CCNK O75909 14/20 0.75
▸ CDK12 Q9NYV4 14/20 0.75
▸ CCNT1 O60563 13/20 0.75
▸ CDK2 P24941 13/20 0.75
▸ MNAT1 P51948 11/20 0.75
▸ CDK13 Q14004 11/20 0.57
▸ CCNA2 P20248 9/20 0.57
▸ CDK3 Q00526 1/20 0.57
▸ RPS6KA3 P51812 1/20 0.57
▸ JUN P05412 2/20 0.53
▸ MAPK8 P45983 2/20 0.53
▸ MAPK9 P45984 2/20 0.53
▸ MAPK10 P53779 1/20 0.53
▸ CDK1 P06493 1/20 0.52
▸ CDK8 P49336 1/20 0.52
▸ CDK5 Q00535 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18072745 0.90 CDK7 (0.88) CDK7CCNHCDK9CCNKCDK12
SCHEMBL16665178 0.90 CDK7 (0.88) CDK7CCNHCDK9CCNKCDK12
SCHEMBL18047265 0.90 CDK7 (0.88) CDK7CCNHCDK9CCNKCDK12
SCHEMBL16665179 0.90 CDK7 (0.88) CDK7CCNHCDK9CCNKCDK12
SCHEMBL16654786 0.88 CDK7 (0.74) CDK7CCNHCDK9CCNKCDK12
SCHEMBL28345975 0.86 CDK7 (0.81) CDK7CCNHCDK9CCNKCDK12
SCHEMBL29366824 0.86 CDK7 (1.00) CDK7CCNHCDK9CCNKCDK12
SCHEMBL17150697 0.86 CDK7 (1.00) CDK7CCNHCDK9CCNKCDK12
SCHEMBL18072813 0.86 CDK7 (0.76) CDK7CCNHCDK9CCNKCDK12
SCHEMBL16654788 0.85 CDK7 (0.71) CDK7CCNHCDK9CCNKCDK12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105849099-B Polycyclic inhibitors of cyclin dependent kinase 7(CDK7) 达纳-法伯癌症研究所股份有限公司 2020-01-17 — — CN disclosed
Send feedback